Detecting cancers at their earliest stage increases the chance of long-term survival.
This solution brief from Bio-Techne describes the drawbacks of relying on circulating tumor DNA for non-invasive early cancer detection and how incorporating proteomics can enhance the sensitivity of early detection tests.
Offered Free by: Bio-Techne
See All Resources from: Bio-Techne